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Abstract
Objective: To determine the prevalence of exercise-induced bronchoconstriction among elite long-distance 
runners in Brazil and whether there is a difference in the training loads among athletes with and without 
exercise-induced bronchoconstriction. Methods: This was a cross-sectional study involving elite long-distance 
runners with neither current asthma symptoms nor a diagnosis of exercise-induced bronchoconstriction. All of 
the participants underwent eucapnic voluntary hyperpnea challenge and maximal cardiopulmonary exercise tests, 
as well as completing questionnaires regarding asthma symptoms and physical activity, in order to monitor their 
weekly training load. Results: Among the 86 male athletes recruited, participation in the study was agreed to by 
20, of whom 5 (25%) were subsequently diagnosed with exercise-induced bronchoconstriction. There were no 
differences between the athletes with and without exercise-induced bronchoconstriction regarding anthropometric 
characteristics, peak oxygen consumption, baseline pulmonary function values, or reported asthma symptoms. 
The weekly training load was significantly lower among those with exercise-induced bronchoconstriction than 
among those without. Conclusions: In this sample of long-distance runners in Brazil, the prevalence of exercise-
induced bronchoconstriction was high.
Keywords: Athletes; Asthma, exercise-induced; Exercise test.
Resumo
Objetivo: Determinar a prevalência de broncoespasmo induzido por exercício em corredores brasileiros de longa 
distância de elite e se há uma diferença na carga de treinamento entre atletas com e sem broncoespasmo induzido 
por exercício. Métodos: Estudo transversal com corredores de longa distância de elite sem sintomas atuais de 
asma e sem diagnóstico de broncoespasmo induzido por exercício. Todos os participantes foram submetidos 
ao teste de hiperventilação voluntária eucápnica e ao teste cardiopulmonar de esforço máximo e responderam 
a questionários sobre sintomas de asma e atividade física para monitorizar sua carga de treinamento semanal. 
Resultados: Dos 86 atletas do sexo masculino recrutados, 20 concordaram em participar do estudo, dos quais 
5 (25%) foram diagnosticados com broncoespasmo induzido por exercício. Não foram evidenciadas diferenças 
entre os atletas com e sem broncoespasmo induzido por exercício em relação a características antropométricas, 
consumo de oxigênio de pico, valores basais de função pulmonar ou sintomas de asma relatados. A carga de 
treinamento semanal foi significativamente menor nos atletas com broncoespasmo induzido por exercício do 
que naqueles sem esse diagnóstico. Conclusões: Nesta amostra de corredores de longa distância brasileiros, a 
prevalência de broncoespasmo induzido por exercício foi alta.
Descritores: Atletas; Asma induzida por exercício; Teste de esforço.
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predictors of EIB and, therefore, should not be 
the sole basis for prescribing medications.(4,15) 
Interestingly, the International Olympic Committee 
has reported that the notification of β2 agonist 
use by athletes correlates with the prevalence of 
asthma symptoms in all countries except Brazil; 
although the country ranks 8th among those 
where the prevalence of asthma is highest, only 
0.7% of Brazilian athletes have reported using 
β2 agonists.(17) This suggests that the prevalence 
of EIB in Brazilian athletes is underestimated.
To our knowledge, there are no studies in 
the literature evaluating the prevalence of EIB in 
Brazilian athletes. Therefore, the main objective of 
the present study was to determine the prevalence 
of EIB among elite long-distance runners in Brazil 
and whether there is a difference in the training 
loads among athletes with and without EIB.
Methods
We recruited 86 male athletes from among 
those in the elite category of the most prestigious 
long-distance street race in Brazil, known as 
Corrida de São Silvestre, which is held in the 
city of São Paulo every December 31st. In order 
to take part in the elite category, male athletes 
have to prove, with documentation, that they 
can run either a half marathon in no longer 
than 66 min or a full marathon in no longer 
than 138 min. During packet pick-up in the 
week prior to the race, elite male runners were 
informed of the objective of the study and were 
invited to leave their phone numbers for future 
contact. Thirty days after the race, 86 athletes 
were contacted, and 20 accepted to take part 
in the study. The reasons why the remaining 
66 athletes declined to participate in the study 
included living far from the city of São Paulo, in 
42; not having time to participate, in 14; and a 
lack of interest, in 10. The inclusion criteria were 
being a Brazilian male; having a peak oxygen 
consumption (VO2) ≥ 65 mL • kg
−1
 • min−1,(18) as 
confirmed by cardiopulmonary exercise testing 
(described below); and having no history of 
cardiopulmonary disease. The exclusion criteria 
were being unwilling to perform spirometry or 
the EVH test and being under treatment with 
asthma medications. All of the athletes who 
agreed to participate in the study gave written 
informed consent prior to the enrollment in 
the study. The clinical protocol was approved 
by the local human research ethics committee. 
Introduction
Exercise-induced bronchoconstriction (EIB) 
is characterized by a transient narrowing of the 
airways during and (more often) after strenuous 
physical effort.(1) Although it occurs predominantly 
in individuals with asthma or atopy,(2,3) EIB has 
been frequently observed in endurance athletes, 
especially long-distance runners.(4,5) This relatively 
high prevalence of EIB in athletes might be due to 
exercise-related factors, such as hyperventilation, 
prolonged exposure to allergens or bronchial 
irritants, and excessive inhalation of cold dry air.(6)
Several studies have reported that the 
prevalence of EIB, which ranges from 3.7% 
to 60%, is higher in elite athletes than in the 
general population.(7,8) This discrepancy can be 
partly explained by the type of sport practiced, 
the environmental conditions, and the method 
used in order to diagnose EIB.(9) In addition, in 
various studies investigating the prevalence of 
EIB in athletes, the training load has not been 
taken into account. For example, hyperventilation 
during training, together with the inhalation of 
irritants, can contribute to the development of 
respiratory disorders in elite athletes. It has been 
recently demonstrated that training can contribute 
to the development of airway hyperresponsiveness 
in elite athletes.(10)
The methods used in order to identify EIB 
are critical to making an accurate diagnosis. 
According to the International Olympic Committee, 
the eucapnic voluntary hyperpnea (EVH) test is 
the most sensitive method for identifying EIB in 
athletes.(11) This challenge test indirectly causes 
bronchial smooth muscle contraction by releasing 
inflammatory mediators.(12) The hyperosmolar 
stimulus induced by EVH and the subsequent 
airway injury induced by the high ventilation 
rate are considered to reflect what occurs during 
strenuous exercise.(13,14) The EVH test was developed 
in order to simulate the effects that ventilation 
at high flow rates has on the airway surface 
liquid, creating a drying and osmotic effect.(15)
Objective documentation of asthma or EIB 
as a prerequisite for an athlete to be allowed 
to use inhaled β2 agonists was first introduced 
at the 2002 Winter Olympic Games. Although 
the use of albuterol and salmeterol in sports 
has recently been permitted, all other inhaled 
β2 agonists remain prohibited.(16) Studies have 
suggested that exercise-related respiratory 
symptoms, as reported by elite athletes, are poor 
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The EVH test was used in order to identify EIB, 
having been performed with the abovementioned 
metabolic cart and pneumotachograph 
(SensorMedics). The equipment was calibrated 
with a 3-L syringe prior to each test, and the 
software allowed us to monitor minute ventilation 
in real time. All of the participants inhaled a 
cold, dry gas mixture (5% carbon dioxide and 
20.9% oxygen) balanced with nitrogen. The 
participants were asked to take a deep breath 
in order to maintain a target minute ventilation 
of 30 times the FEV1 for 6 min. The volume was 
monitored on the computer screen, and verbal 
encouragement was given in case the minute 
ventilation fell below the target. A positive EVH 
test was defined as a ≥ 10% fall in FEV1 from 
the baseline (pre-EVH) value.(11)
The ISAAC written questionnaire, previously 
validated for use in adults, was used in order 
to document asthma symptoms.(25) The ISAAC 
questionnaire comprises eight questions, each 
having a score ranging from 0 to 2, with a total 
score of 14. A score ≥ 5 indicates the presence 
of asthma symptoms.(25) In addition, all of the 
participants were asked four questions concerning 
their training habits, in order to obtain information 
regarding their training load.
Statistical analyses were performed with 
the Statistical Package for the Social Sciences, 
version 13.0 (SPSS Inc., Chicago, IL, USA). We used 
the Kolmogorov-Smirnov test and the Levene test 
in order to determine the homogeneity of variance 
between the groups. Numerical variables, such 
as age, body mass index, peak VO2, pulmonary 
function parameters, and weekly training load, 
were compared by the Student’s t-test. The 
prevalence of EIB was expressed in percentage. 
Statistical significance was set at p < 0.05, and the 
numerical variables were expressed as mean ± SD.
Results
Of the 20 elite athletes evaluated, 5 were 
classified as EIB+. In the EIB+ group, post-EVH 
FEV1 was significantly lower than baseline 
FEV1 (p < 0.05), with peaks at 5 and 10 min 
(Figure 1). The anthropometric characteristics 
of the athletes, as well as peak VO2 and baseline 
pulmonary function variables, are presented in 
Table 1. All of the individuals in the EIB+ group 
presented with cough after the EVH test, and 2 
also presented with wheezing. Interestingly, cough 
was also observed in 4 individuals in the EIB− 
The present study was performed in accordance 
with recognized ethical standards, as well as with 
national and international laws.(19)
This was a cross-sectional study consisting of 
two visits on different days, with an interval of 
two weeks between the visits. In the first visit, all 
of the participants completed the International 
Study of Asthma and Allergies in Childhood 
(ISAAC) questionnaire on asthma symptoms, as 
well as a questionnaire to quantify the training 
load. In addition, the physical characteristics of 
the athletes were determined, and pulmonary 
function was assessed at rest, being immediately 
followed by a cardiopulmonary exercise test to 
determine peak VO2. In the second visit, the 
participants were submitted to pulmonary function 
testing prior to and after EVH challenge. Those 
with a fall ≥ 10% in FEV1 after EVH challenge 
were classified as testing positive for EIB (EIB+), 
whereas those with a fall < 10% in FEV1 after 
EVH challenge were classified as testing negative 
for EIB (EIB−).(20)
Peak VO2 was determined by treadmill ramp 
protocol cardiopulmonary exercise testing until 
exhaustion. The athletes were advised to refrain 
from coffee, caffeinated beverages, alcohol, 
and physical exercise 24 h prior to the test. 
Blood pressure, HR, and electrocardiographic 
activity were continuously monitored with an 
electrocardiogram, whereas ventilation, VO2, carbon 
dioxide output, and oxygen pulse were monitored 
with a metabolic cart and a pneumotachograph 
(229 Vmax™; SensorMedics, Yorba Linda, CA, 
USA). Gas fractions were analyzed with oxygen 
and carbon dioxide analyzers calibrated with 
standard gases of known concentrations. The 
athletes had to achieve at least 95% of the 
age-predicted maximal HR(21) and a respiratory 
exchange ratio > 1.15 at peak physical exertion.(22)
All of the participants underwent pulmonary 
function testing with a computerized 
pneumotachograph spirometer (SensorMedics), in 
accordance with the American Thoracic Society 
recommendations.(23) The maximum fall in FEV1 
from the baseline (pre-EVH) value was calculated 
by the following formula, expressed in percentage:
[(pre-EVH FEV1 − lowest post-EVH FEV1) ÷ 
 (pre-EVH FEV1)] × 100
Pulmonary function test results were compared 
with the predicted reference values for Brazilian 
adults.(24)
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Discussion
The objective of the present study was to 
evaluate the prevalence of EIB in elite long-
distance runners in Brazil. Of the 20 runners under 
study, 5 (25%) tested positive for EIB, despite 
having no history of pulmonary dysfunction 
or asthma symptoms. Although peak VO2 was 
found to be similar between the EIB+ and EIB− 
groups, the running distance covered per week 
was significantly shorter in the former.
In our study, 25% of the elite long-distance 
runners presented with EIB after the EVH test, 
which suggests a disparity between our results 
group. During the EVH test, all of the athletes 
were able to maintain the target ventilation for 
6 min, and there was no difference between 
the EIB+ and EIB− groups (124.5 ± 12.6 L/min 
vs. 122.8 ± 10.7 L/min; p = 0.8). None of the 
athletes had a score ≥ 5 (indicative of asthma 
symptoms) on the ISAAC questionnaire (Table 2). 
The weekly training load was found to be lower 
in the athletes in the EIB+ group than in those 
in the EIB− group (p < 0.05; Table 2). Regarding 
the training habits, the average running distance 
covered per week was the only parameter that 
showed a statistically significant difference 
between the EIB + and EIB− groups (Table 2).
Table 1 - Baseline anthropometric data, peak oxygen consumption, and baseline pulmonary function 
parameters in the athletes with and without exercise-induced bronchoconstriction.a
Variable Total EIB+ EIB− p
(n = 20) (n = 5) (n = 15)
Age, years 30.5 ± 5.2 29.0 ± 5.0 31.1 ± 5.3 0.45
BMI, kg/m2 20.8 ± 1.6 20.6 ± 2.2 20.8 ± 1.5 0.80
Peak VO2, mL • kg
−1
 • min−1 63.8 ± 5.6 63.4 ± 9.3 64.0 ± 4.1 0.83
FEV1, L 4.03 ± 0.52 3.86 ± 0.40 4.10 ± 0.56 0.38
FEV1, % of predicted 101.0 ± 12.5 98 ± 8.4 103.0 ± 13.0 0.37
FVC, L 4.60 ± 0.50 4.38 ± 0.67 4.68 ± 0.44 0.25
FVC, % of predicted 98.3 ± 8.9 94.0 ± 11.1 100.0 ± 8.0 0.23
FEV1/FVC ratio 86.2 ± 7.9 86.0 ± 6.6 86.3 ± 8.5 0.89
FEV1/FVC ratio, % of predicted  100.4 ± 8.4 98.0 ± 3.3 101.0 ± 9.6 0.12
FEF25-75%, L/s 5.11 ± 1.20 4.67 ± 1.32 5.26 ± 1.19 0.36
FEF25-75%, % predicted 110 ± 24 104 ± 25 112 ± 24 0.55
EIB: exercise-induced bronchoconstriction; BMI: body mass index; and VO2: oxygen consumption. 
aValues expressed 
as mean ± SD.
Figure 1 - Difference (in %) between baseline FEV1 and FEV1 at different time points after eucapnic voluntary 
hyperpnea challenge in the groups of athletes with and without exercise-induced bronchoconstriction (EIB+ 
and EIB−, respectively). A fall of at least 10% in FEV1 after the EVH test is diagnostic of EIB. *p < 0.05.
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answering the ISAAC questionnaire; this suggests 
that respiratory symptoms are poor predictors of 
EIB,(26,29) which reinforces the need to perform 
the EVH test in elite athletes performing aerobic 
exercise in order to document EIB. Symptoms 
reported in questionnaires alone are likely to 
provide a limited perspective, the agreement 
between self-reported symptoms and objective 
measurements of airway dysfunction being poor.(4)
There is evidence suggesting that, in athletes, 
longer periods of aerobic training translate to 
a greater likelihood of developing EIB.(14) In 
addition, EIB in athletes without asthma is a 
distinct entity from that in those with asthma. 
Therefore, it is possible that two different types 
of EIB occur in athletes: EIB that is due to 
high-intensity, long-term endurance training; 
and EIB that is due to asthma, being elicited by 
increased ventilation.(30) However, this hypothesis 
needs further investigation.
In the present study, the difference between 
EIB+ and EIB− athletes cannot be explained by 
the history of training, which was similar in the 
two groups (mean, 8 years; Table 2). Surprisingly, 
the athletes in the EIB+ group reported covering 
a shorter running distance during their training 
than did those in the EIB− group. This might 
be due to ventilatory limitation (bronchial 
obstruction) in the athletes in the EIB+ group; 
however, in the present study, this aspect was 
not assessed. It is of note that peak VO2 values 
were similar between the two groups of athletes, 
which suggests that EIB was not due to a lack of 
fitness. Our results do not allow us to establish 
a cause-and-effect relationship between the 
training load and the occurrence of EIB, further 
studies being therefore required.
This is the first study to assess the prevalence 
of EIB in Brazilian runners. The relevance of 
our study lies in the fact that the number of 
and those reported in a study involving Brazilian 
Olympic athletes (prevalence of EIB, 0.7%).(17) In 
our opinion, there are two possible explanations 
for such a discrepancy. First, the EVH test, used 
in the present study in order to diagnose EIB, 
is not routinely performed in athletes in Brazil, 
which might explain the small number of athletes 
who reported using β2 agonists in that study.(17) 
Second, Brazilian athletes do not always seek 
medical attention for respiratory problems, either 
because they are unaware that they have such 
problems or because they mistake respiratory 
symptoms for difficulty breathing due to heavy 
physical exertion. We cannot compare our findings 
with those of other, similar, studies conducted in 
Brazil, because none of those studies evaluated the 
prevalence of EIB in Brazilian runners. However, 
because we used the EVH test, which is the 
gold standard for the diagnosis of EIB, we can 
hypothesize that the prevalence of EIB in elite 
Brazilian athletes is underestimated. There are 
studies suggesting that the prevalence of EIB 
in winter sports athletes ranges from 17% to 
25%.(26,27) Interestingly, the prevalence of EIB 
in our athletes was found to be as high as that 
reported in winter sports athletes. Although it is 
impossible to explain the high prevalence of EIB 
in our study, we can speculate that, in winter 
sports athletes, EIB is due to the inhalation of 
cold air, whereas, in our athletes, EIB is due to 
environmental conditions, such as high levels 
of air pollution.
Although all of the EIB+ athletes in the present 
study presented with cough after the EVH test, 
none had reported exercise-related respiratory 
symptoms prior to the test. Our results are in 
agreement with those of other studies, suggesting 
that athletes do not easily perceive or recognize 
respiratory symptoms.(26,28) In our study, none of 
the athletes reported asthma symptoms when 
Table 2 - Asthma symptoms and training habits in the athletes with and without exercise-induced 
bronchoconstriction.a
Variable EIB+ EIB– p
(n = 5) (n = 15)
Having asthma symptoms, nb 0 0 1.0
Years running long distance 7.5 ± 3.9 8 ± 5.7 0.85
Average n of h/week spent running 10.6 ± 1.3 11.7 ± 2.5 0.37
Average running distance covered per week, km 80 ± 23.4 115 ± 26.1 0.01
n days/week running 6.2 ± 0.4 6.3 ± 0.5 0.59
EIB: exercise-induced bronchoconstriction. aValues expressed as mean ± SD. bInternational Study of Asthma and Allergies 
in Childhood questionnaire score ≥ 5.
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runners in Brazil has been increasing, as well 
as in the fact that, in five years’ time, Brazil 
will be hosting the two most important sports 
events in the world, namely the FIFA World Cup 
and the Olympic Games. Therefore, athletes and 
sports-related workers should be aware of all of 
the issues related to the performance of athletes.
The present study has some limitations, which 
should be noted. First, our sample was small 
and might not be truly representative of the 
population of elite Brazilian runners; however, in 
most of the studies in which EVH challenge was 
used in order to evaluate EIB in elite athletes, 
the sample size was similar to ours.(7,9) Second, 
it is difficult to evaluate elite athletes because 
they are constantly required to maintain training; 
therefore, they are seldom interested in taking 
part in studies that are not specifically related to 
physical performance, and most of them claim that 
they cannot participate in such studies because of 
their training and competition schedules. In the 
present study, we found that the athletes were 
concerned about having EIB and the consequences 
thereof, including medical treatment and the 
impact of EIB on their physical performance.
In conclusion, the prevalence of EIB in our 
sample of elite Brazilian runners was high. 
However, this was unrelated to the presence of 
asthma symptoms. Further studies should be 
carried out in order to establish the relationship 
between the occurrence of EIB and the training 
load of athletes.
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